1. Home
  2. PLUR vs ATCH Comparison

PLUR vs ATCH Comparison

Compare PLUR & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$2.09

Market Cap

25.5M

Sector

Health Care

ML Signal

HOLD

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.20

Market Cap

29.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLUR
ATCH
Founded
2001
2022
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
29.6M
IPO Year
2001
2024

Fundamental Metrics

Financial Performance
Metric
PLUR
ATCH
Price
$2.09
$0.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$1.00
AVG Volume (30 Days)
10.1K
1.5M
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
10.78
N/A
EPS
N/A
0.05
Revenue
$1,336,000.00
N/A
Revenue This Year
$97.38
$84.47
Revenue Next Year
$293.97
$39.32
P/E Ratio
N/A
$4.10
Revenue Growth
309.82
N/A
52 Week Low
$1.99
$0.14
52 Week High
$5.96
$1.92

Technical Indicators

Market Signals
Indicator
PLUR
ATCH
Relative Strength Index (RSI) 37.48 44.42
Support Level N/A $0.19
Resistance Level $2.58 $0.22
Average True Range (ATR) 0.12 0.01
MACD 0.02 0.00
Stochastic Oscillator 22.73 45.53

Price Performance

Historical Comparison
PLUR
ATCH

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: